| Ticker Symbol: | BMY |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 345 Park Avenue New York NY 10154 212-546-4000 |
| CEO/President: | James M. Cornelius |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. |
| Shares Outstanding: | 1,979,600 (000) | Market Value: | 42,621,140 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 71.53% | Number of Inst.Shareholders: | 0.00% |
| Last Quarter Sales: | 5203.00 ($Mil.) | Last Quarter Net Income: | 764.00 ($Mil.) |
| Last Quarter EPS: | 0.43 | P/E Ratio: | 14 |
| Most Recent Earnings: | 0.43 on 07/24/08 | Earnings Per Share: | 1.09 |
| Most Recent Split: | 2-1 on 03/01/99 | Annual Dividend Rate: | 1.24 |
| Most Recent Dividend: | 0.310 on 07/02/08 | Annual Dividend Yield: | 5.76% |


| PFIZER INC | -18.50 | 18.67 | |
| MERCK CO INC | -32.60 | 34.17 | |
| JOHNSON AND JOH | +17.90 | 70.45 | |
| SCHERING PLOUGH | -29.30 | 19.16 | |
| BRISTOL MYERS S | -18.00 | 21.50 |
